TB-500 (Thymosin β4 Acetate)

BT

TB-500 is a synthetic version of the active region of thymosin beta-4, an actin-sequestering peptide. It is used in cytoskeletal and repair-model research and is supplied as a lyophilised powder for in-vitro research only.

CAS
77591-33-4
Purity
≥99%
Form
Lyophilised powder
Price
On enquiry

Research contexts

  • Actin-binding and cytoskeletal dynamics studies
  • Cell migration and angiogenesis assay models
  • Comparative research with full-length thymosin beta-4

Listed for reference only. Nothing here describes, suggests or implies any use in humans or animals.

Handling and storage

Store lyophilised at -20 °C. Reconstitute with bacteriostatic or sterile water and refrigerate reconstituted material at 2-8 °C.

Testing and documentation

Batch 2026-06 was analysed by Janoshik Analytical on 19 June 2026 at 99.102% purity. Report #168539 can be verified independently with key VSVNL55F9CLZ.

Related compounds

Research use only. Supplied strictly for in-vitro laboratory research by qualified researchers. Not a therapeutic good, not for human or veterinary use, not for diagnostic purposes, and not for food or cosmetic manufacture. No claims of safety or efficacy are made or implied.